WallStreetZenWallStreetZen

NASDAQ: NBIX
Neurocrine Biosciences Inc Stock Ownership - Who owns Neurocrine Biosciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Neurocrine Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
David W. BoyerCXO2026-09-14826$157.45
$130.05kSell
Matt AbernethyCFO2026-09-142,311$157.20
$363.28kSell
Kyle GanoCEO2026-09-113,386$156.22
$528.96kSell
Kyle GanoCEO2026-09-11994$156.22
$155.28kSell
David W. BoyerCXO2026-09-111,936$156.22
$302.44kSell
Eric BenevichCCO2026-09-113,386$156.22
$528.96kSell
Ingrid DelaetCXO2026-09-112,419$156.22
$377.90kSell
Kevin Charles GormanDirector2026-09-117,839$156.22
$1.22MSell
Sanjay Chandru KeswaniMed2026-09-112,112$156.22
$329.94kSell
Darin LippoldtCLO2026-09-112,419$156.22
$377.90kSell

1 of 13

NBIX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NBIX insiders and whales buy or sell their stock.

NBIX Shareholders

What type of owners hold Neurocrine Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bvf Partners L P34.49%35,058,600$4.92BInsider
Venrock Healthcare Capital Partners LP0.73%739,900$103.91MInsider
Anders D. Hove0.73%739,900$103.91MInsider
Bryan E. Roberts0.73%739,900$103.91MInsider
Kevin Charles Gorman0.51%517,797$72.72MInsider
Gary A. Lyons0.50%505,714$71.02MInsider
Paul W. Hawran0.35%360,144$50.58MInsider
Wylie W. Vale0.23%231,372$32.49MInsider
Haig P. Bozigian0.16%157,651$22.14MInsider
Kyle Gano0.15%154,728$21.73MInsider

1 of 3

NBIX vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NBIX0.10%39.52%Net SellingNet Selling
ELAN0.11%10.49%Net SellingNet Buying
RDY0.02%26.65%
VTRS0.09%18.69%Net SellingNet Selling
ALKS0.11%7.46%Net SellingNet Selling
View Top Pharmaceutical Stocks

Neurocrine Biosciences Stock Ownership FAQ

Who owns Neurocrine Biosciences?

Neurocrine Biosciences (NASDAQ: NBIX) is owned by 0.10% institutional shareholders, 39.52% Neurocrine Biosciences insiders, and 60.38% retail investors. Bvf Partners L P is the largest individual Neurocrine Biosciences shareholder, owning 35.06M shares representing 34.49% of the company. Bvf Partners L P's Neurocrine Biosciences shares are currently valued at $4.85B.

If you're new to stock investing, here's how to buy Neurocrine Biosciences stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.